EOD GH Dosing: Lower Exposure, Same IGF-1

EOD GH can maintain IGF-1 while reducing total weekly exposure

IGF-1 response often plateaus before GH dose does

More GH doesn’t mean proportionally more IGF-1

Hepatic IGF-1 production is highly sensitive not linear.

Lower exposure often means better long-term tolerability

Recovery markers matter more than chasing peak IGF-1.

GH’s downstream effects persist beyond its short half life

Sleep quality can improve with less frequent GH pulses

Insulin sensitivity may be easier to manage on EOD

Higher doses daily increase sides faster than benefits

EOD dosing reduces cumulative stress on glucose handling

Bloodwork should guide frequency not bro logic